Bronchiectasis Research Study at Shanghai Hospital
Part of Lungs & breathing clinical trials.
This study looks at the genes and health data of people with bronchiectasis to better understand the disease. It may help find new ways to treat or manage your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with bronchiectasis (a lung condition that causes widened, scarred airways).
- You have symptoms like cough, phlegm, or frequent chest infections.
- You have not had a lung flare-up that needed antibiotics or steroids in the last month.
- You are at least 18 years old.
- You do not have active tuberculosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how bronchiectasis (ongoing lung damage with mucus and infections) may happen by using your medical records and genetic information. It may help researchers find better ways to understand different bronchiectasis types and guide future treatments.
This study looks at what factors are linked to flare-ups and serious outcomes in people with non–cystic fibrosis bronchiectasis. You may be followed because your lung scans and recent stability help researchers understand what predicts worsening.
This study looks at why bronchiectasis gets worse over time. It may help doctors understand the disease better and find better ways to monitor or treat it.
This study looks at how bacteria live in the lungs of people with bronchiectasis and how they may adapt over time. It may help researchers understand why infections keep coming back and how to better manage chronic lung colonization.
This study looks at how different types of inflammation in your sputum (mucus you cough up) relate to your lung health over time. It aims to understand why some people with bronchiectasis do better than others, which may help improve future treatments.
This trial tests if a new drug, GSK3862995B, is safe and effective for adults with bronchiectasis. It might help reduce lung infections and improve symptoms.
Hear when a new Bronchiectasis Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.